Infecciones en cirugía | 10 OCT 07
Infecciones complejas: manejo quirúrgico y antibiótico (2º Parte)
Esta actualización se enfoca en el manejo de estrategias para las infecciones intraabdominales complicadas de la piel y sus anexos.
Autor/a: Dres. Napolitano LM, Sawyer RG, Stevens DL. Contemporary Surgery, Supplement, December 2006
Desarrollo
1. Mazuski JE, Sawyer RG, Nathens AB, et al, for the Therapeutic Agents Committee of the Surgical Infections Society. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary. Surg Infect (Larchmt). 2002;3:161-173.
2. Malangoni MA. Contributions to the management of intraabdominal infections. Am J Surg. 2005;190:255-259.
3. Solomkin JS, Mazuski JE, Baron EJ, et al. Guidelines for the selection of antiinfective agents for complicated intra-abdominal infections. Clin Infect Dis.
2003;37:997-1005.
4. Malangoni MA, Song J, Herrington J, Choudri S, Pertel P. Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections. Ann Surg. 2006;244:204-211.
5. Babinchak T, Ellis-Grosse E, Dartois N, Rose GM, Loh E, for the Tigecycline 301 and 306 Study Groups. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Clin Infect Dis. 2005;41(suppl 5):S354-S367.
6. Drago M, Scaltrito MM, Morace G, for the GISIA-2 Group. In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei. Eur J Clin Microbiol Infect Dis. 2004;23:619-6
Comentarios
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024